Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era
Crossref DOI link: https://doi.org/10.1007/s11255-017-1703-y
Published Online: 2017-09-20
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marchioni, Michele http://orcid.org/0000-0002-1702-4127
Bandini, Marco
Pompe, Raisa S.
Tian, Zhe
Martel, Tristan
Kapoor, Anil
Cindolo, Luca
Berardinelli, Francesco
Briganti, Alberto
Shariat, Shahrokh F.
Schips, Luigi
Karakiewicz, Pierre I.
License valid from 2017-09-20